Food: The Forgotten Factor in the Irritable Bowel Syndrome

Gastroenterology Clinics of North America

Volumn 40, Issue 1, 2011, Pages 141-162

  Eswaran, Shanti ^a   Tack, Jan ^b   Chey, William D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Carbohydrate; Diet; FODMAP; Fructose; Gluten; Lactose; Lipid

Indexed keywords

CARBOHYDRATE; CHOLECYSTOKININ; FRUCTOSE; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 40; GLUCAGON LIKE PEPTIDE 1; GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; ISPAGULA; LACTOSE; PLACEBO; SODIUM GLUCOSE COTRANSPORTER 1;

ARTICLE; CELIAC DISEASE; CONSTIPATION; DIARRHEA; DIET THERAPY; DIETARY FIBER; DISEASE ASSOCIATION; DRUG DOSE TITRATION; FOOD ALLERGY; GLUTEN FREE DIET; HUMAN; INTESTINE BIOPSY; IRRITABLE COLON; LOW CARBOHYDRATE DIET; NUTRITIONAL INTOLERANCE; RISK ASSESSMENT; SYMPTOMATOLOGY;

EID: 79951573900     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2010.12.012     Document Type: Review

References (128)

1. Chey W.D., Olden K., Carter E., et al. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol 2002, 97(11):2803-2811.
2. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 2006, 130(5):1480-1491.
3. Monsbakken K.W., Vandvik P.O., Farup P.G. Perceived food intolerance in subjects with irritable bowel syndrome-etiology, prevalence and consequences. Eur J Clin Nutr 2005, 60(5):667-672.
4. Young E., Stoneham M.D., Petruckevitch A., et al. A population study of food intolerance. Lancet 1994, 343(8906):1127-1130.
5. Locke G.R., Zinsmeister A.R., Talley N.J., et al. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000, 95(1):157-165.
6. Crespo J.F., Rodriguez J. Food allergy in adulthood. Allergy 2003, 58(2):98-113.
7. Jarrett M., Visser R., Heitkemper M. Diet triggers symptoms in women with irritable bowel syndrome. The patient's perspective. Gastroenterol Nurs 2001, 24(5):246-252.
8. Bischoff S.C., Herrmann A., Manns M.P. Prevalence of adverse reactions to food in patients with gastrointestinal disease. Allergy 1996, 51(11):811-818.
9. Simrén M., Månsson A., Langkilde A.M., et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001, 63(2):108-115.
10. Dainese R., Galliani E.A., De Lazzari F., et al. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999, 94(7):1892-1897.
11. Nanda R., James R., Smith H., et al. Food intolerance and the irritable bowel syndrome. Gut 1989, 30(8):1099-1104.
12. Jones V.A., Shorthouse M., Hunter J.O. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982, 2(8308):1115-1117.
13. Bhat K., Harper A., Gorard D.A. Perceived food and drug allergies in functional and organic gastrointestinal disorders. Aliment Pharmacol Ther 2002, 16(5):969-973.
14. Anderson J. The clinical spectrum of food allergy in adults. Clin Exp Allergy 1991, 21:304-315.
15. Arslan G., Kahrs G.E., Lind R., et al. Patients with subjective food hypersensitivity: the value of analyzing intestinal permeability and inflammation markers in gut lavage fluid. Digestion 2004, 70(1):26-35.
16. Iacono G., Cavataio F., Montalto G., et al. Intolerance of cow's milk and chronic constipation in children. N Engl J Med 1998, 339(16):1100-1104.
17. Stefanini G.F., Bazzocchi G., Prati E., et al. Efficacy of oral disodium cromoglycate in patients with irritable bowel syndrome and positive skin prick tests to foods. Lancet 1986, 1(8474):207-208.
18. Niec A.M., Frankum B., Talley N.J. Are adverse food reactions linked to irritable bowel syndrome?. Am J Gastroenterol 1998, 93(11):2184-2190.
19. Read N.W. Food and hypersensitivity in functional dyspepsia. Gut 2002, 51(Suppl 1):i50-i53.
20. Zar S., Benson M.J., Kumar D. Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome. Am J Gastroenterol 2005, 100(7):1550-1557.
21. Zar S., Kumar D., Benson M.J. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther 2001, 15(4):439-449.
22. Saito Y.A., Locke G.R., Weaver A.L., et al. Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol 2005, 100(12):2743-2748.
23. Halpert A., Dalton C.B., Palsson O., et al. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National survey on patient educational needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol 2007, 102(9):1972-1982.
24. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006, 131(2):640-658.
25. Stanley S., Wynne K., McGowan B., et al. Hormonal regulation of food intake. Physiol Rev 2005, 85(4):1131-1158.
26. Dockray G.J. Luminal sensing in the gut: an overview. J Physiol Pharmacol 2003, 54(Suppl 4):9-17.
27. Tack J., Caenepeel P., Corsetti M., et al. Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 2004, 127(4):1058-1066.
28. Vanden Berghe P., Janssen P., Kindt S., et al. Contribution of different triggers to the gastric accommodation reflex in humans. Am J Physiol Gastrointest Liver Physiol 2009, 297(5):G902-G906.
29. Wiley J., Tatum D., Keinath R., et al. Participation of gastric mechanoreceptors and intestinal chemoreceptors in the gastrocolonic response. Gastroenterology 1988, 94(5 Pt 1):1144-1149.
30. Sims M.A., Hasler W.L., Chey W.D., et al. Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans. Gastroenterology 1995, 108(2):350-359.
31. Stanghellini V., Borovicka J., Read N.W. Feedback regulation and sensation. Frontiers in gastric emptying. Dig Dis Sci 1994, 39(Suppl 12):124S-127S.
32. Tanaka T., Katsuma S., Adachi T., et al. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol 2008, 377(4-6):523-527.
33. Karaus M., Niederau C. Effects of CCK-receptor antagonist on colonic motor activity in dogs. Neurogastroenterol Motil 1995, 7(2):63-71.
34. Niederau C., Faber S., Karaus M. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome. Gastroenterology 1992, 102(6):1889-1898.
35. Simren M., Abrahamsson H., Bjornsson E.S. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001, 48(1):20-27.
36. Simren M., Agerforz P., Bjornsson E.S., et al. Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS). Neurogastroenterol Motil 2007, 19(1):20-29.
37. Sabate J.M., Gorbatchef C., Flourie B., et al. Cholecystokinin octapeptide increases rectal sensitivity to pain in healthy subjects. Neurogastroenterol Motil 2002, 14(6):689-695.
38. Raybould H.E. Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci 2010, 153(1-2):41-46.
39. Heizer W.D., Southern S., McGovern S. The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. J Am Diet Assoc 2009, 109(7):1204-1214.
40. Rozengurt E., Sternini C. Taste receptor signaling in the mammalian gut. Curr Opin Pharmacol 2007, 7(6):557-562.
41. Boesmans W., Owsianik G., Tack J., et al. TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol 2011, 162:18-37.
42. Skoog S.M., Bharucha A.E., Camilleri M., et al. Effects of an osmotically active agent on colonic transit. Neurogastroenterol Motil 2006, 18(4):300-306.
43. Koutsou G.A., Storey D.M., Lee A., et al. Dose-related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate. Eur J Clin Nutr 1996, 50(1):17-21.
44. Schmid H.R., Ehrlein H.J. Effects of enteral infusion of hypertonic saline and nutrients on canine jejunal motor patterns. Dig Dis Sci 1993, 38(6):1062-1072.
45. Marciani L., Cox E.F., Hoad C.L., et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology 2010, 138(2):469-477. e461.
46. Grabitske H.A., Slavin J.L. Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr 2009, 49(4):327-360.
47. Lee K.J., Tack J. Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil 2010, 22(5):493-498.
48. Cianferoni A., Spergel J.M. Food allergy: review, classification and diagnosis. Allergol Int 2009, 58(4):457-466.
49. Brandtzaeg P. Food allergy: separating the science from the mythology. Nat Rev Gastroenterol Hepatol 2010, 7(9):478.
50. Bock S. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987, 79:683-688.
51. Sampson H.A., Sicherer S.H., Birnbaum A.H. AGA technical review on the evaluation of food allergy in gastrointestinal disorders. Gastroenterology 2001, 120(4):1026-1040.
52. Sampson H.A. Update on food allergy. J Allergy Clin Immunol 2004, 113(5):805-819.
53. Bruijnzeel-Koomen C., Ortolani C., Aas K., et al. Adverse reactions to food. Allergy 1995, 50(8):623-635.
54. Sicherer S.H., Sampson H.A. Food allergy. J Allergy Clin Immunol 2010, 125(2 Suppl 2):S116-S125.
55. Smith M.A., Youngs G.R., Finn R. Food intolerance, atopy, and irritable bowel syndrome. Lancet 1985, 2(8463):1064.
56. Powell N., Huntley B., Beech T., et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J 2007, 83(977):182-186.
57. Tobin M.C., Moparty B., Farhadi A., et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol 2008, 100(1):49-53.
58. Roussos A., Koursarakos P., Patsopoulos D., et al. Increased prevalence of irritable bowel syndrome in patients with bronchial asthma. Respir Med 2003, 97(1):75-79.
59. Pires G.V., Souza H.S., Elia C.C., et al. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc 2004, 25(4):253-259.
60. Kokkonen J., Simila S., Herva R. Gastrointestinal findings in atopic children. Eur J Pediatr 1980, 134(3):249-254.
61. Caffarelli C., Cavagni G., Romanini E., et al. Duodenal IgE-positive cells and elimination diet responsiveness in children with atopic dermatitis. Ann Allergy Asthma Immunol 2001, 86(6):665-670.
62. Kalimo K., Lammintausta K., Klemi P., et al. Mast cells and IgE in intestinal mucosa in adult atopic dermatitis patients. Br J Dermatol 1988, 119(5):579-585.
63. Stefanini G.F., Prati E., Albini M.C., et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol 1992, 87(1):55-57.
64. Pike M.G., Heddle R.J., Boulton P., et al. Increased intestinal permeability in atopic eczema. J Invest Dermatol 1986, 86(2):101-104.
65. Jackson P.G., Lessof M.H., Baker R.W., et al. Intestinal permeability in patients with eczema and food allergy. Lancet 1981, 1(8233):1285-1286.
66. Dunlop S.P., Hebden J., Campbell E., et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006, 101(6):1288-1294.
67. Lillestol K., Helgeland L., Arslan Lied G., et al. Indications of 'atopic bowel' in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther 2010, 31(10):1112-1122.
68. Ohman L., Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010, 7(3):163-173.
69. Atkinson W., Sheldon T.A., Shaath N., et al. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004, 53(10):1459-1464.
70. Carroccio A., Brusca I., Mansueto P., et al. A cytologic assay for diagnosis of food hypersensitivity in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2010, 8(3):254-260.
71. Bischoff S.C., Mayer J., Wedemeyer J., et al. Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. Gut 1997, 40(6):745-753.
72. Bentley S.J., Pearson D.J., Rix K.J. Food hypersensitivity in irritable bowel syndrome. Lancet 1983, 2(8345):295-297.
73. Petitpierre M., Gumowski P., Girard J.P. Irritable bowel syndrome and hypersensitivity to food. Ann Allergy 1985, 54(6):538-540.
74. Zwetchkenbaum J.F., Burakoff R. Food allergy and the irritable bowel syndrome. Am J Gastroenterol 1988, 83(9):901-904.
75. McKee A.M., Prior A., Whorwell P.J. Exclusion diets in irritable bowel syndrome: are they worthwhile?. J Clin Gastroenterol 1987, 9(5):526-528.
76. Ford A.C., Talley N.J., Spiegel B.M., et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008, 337:a2313.
77. Francis C.Y., Whorwell P.J. Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994, 344(8914):39-40.
78. Bijkerk C.J., de Wit N.J., Muris J.W., et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ 2009, 339:b3154.
79. King T.S., Elia M., Hunter J.O. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998, 352(9135):1187-1189.
80. Fasano A., Berti I., Gerarduzzi T., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003, 163(3):286-292.
81. Green P.H., Jabri B. Coeliac disease. Lancet 2003, 362(9381):383-391.
82. Ford A.C., Chey W.D., Talley N.J., et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009, 169(7):651-658.
83. Saito-Loftus Y., Almazar-Elder A., Larson J., et al. ROME Criteria for Irritable Bowel Syndrome (IBS) should be a quantitative trait and not a qualitative trait. Am J Gastroenterol 2008, 103(Suppl 1):S472.
84. Cash B., Lee D., Riddle M., et al. Yield of diagnostic testing in patients with suspected Irritable Bowel Syndrome (IBS): a prospective, U.S. Multi-Center Trial. Am J Gastroenterol 2008, 103(Suppl 1):S462.
85. Wahnschaffe U., Schulzke J.D., Zeitz M., et al. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007, 5(7):844-850. [quiz: 769].
86. Verdu E.F., Armstrong D., Murray J.A. Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol 2009, 104(6):1587-1594.
87. Wahnschaffe U., Ullrich R., Riecken E.O., et al. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001, 121(6):1329-1338.
88. Loft D.E., Nwokolo C.U., Ciclitira P.J. The diagnosis of gluten sensitivity and coeliac disease-the two are not mutually inclusive. Eur J Gastroenterol Hepatol 1998, 10(11):911-913.
89. Drossman D.A., Camilleri M., Mayer E.A., et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123:2108-2131. Abstract|PDF (285 K)|View Record in Scopus|Cited By in Scopus (505).
90. Marshall J.K., Thabane M., Garg A.X., et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006, 131(2):445-450. [quiz: 660].
91. Spiller R.C., Jenkins D., Thornley J.P., et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47(6):804-811.
92. Neal K.R., Hebden J., Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997, 314(7083):779-782.
93. Pimentel M., Chow E.J., Lin H.C. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003, 98(2):412-419.
94. Gwee K.A., Collins S.M., Read N.W., et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003, 52(4):523-526.
95. Kurppa K., Collin P., Viljamaa M., et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009, 136(3):816-823.
96. Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997, 3(7):797-801.
97. Kaukinen K., Maki M., Partanen J., et al. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci 2001, 46(4):879-887.
98. Vande Voort J.L., Murray J.A., Lahr B.D., et al. Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol 2009, 104(1):142-148.
99. Suchy F.J., Brannon P.M., Carpenter T.O., et al. National Institutes of Health Consensus Development Conference: lactose intolerance and health. Ann Intern Med 2010, 152(12):792-796.
100. Law D., Conklin J., Pimentel M. Lactose intolerance and the role of the lactose breath test. Am J Gastroenterol 2010, 105(8):1726-1728.
101. Lomer M.C., Parkes G.C., Sanderson J.D. Review article: lactose intolerance in clinical practice-myths and realities. Aliment Pharmacol Ther 2008, 27(2):93-103.
102. Casellas F., Aparici A., Casaus M., et al. Subjective perception of lactose intolerance does not always indicate lactose malabsorption. Clin Gastroenterol Hepatol 2010, 8(7):581-586.
103. Brandt L.J., Chey W.D., Foxx-Orenstein A.E., et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009, 104(Suppl 1):S1-S35.
104. Alpers D.H. Diet and irritable bowel syndrome. Curr Opin Gastroenterol 2006, 22(2):136-139.
105. Corlew-Roath M., Di Palma J.A. Clinical impact of identifying lactose maldigestion or fructose malabsorption in irritable bowel syndrome or other conditions. South Med J 2009, 102(10):1010-1012.
106. Shaukat A., Levitt M.D., Taylor B.C., et al. Systematic review: effective management strategies for lactose intolerance. Ann Intern Med 2010, 152(12):797-803.
107. Rumessen J.J., Gudmand-Hoyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 1988, 95(3):694-700.
108. Gibson P.R., Newnham E., Barrett J.S., et al. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007, 25(4):349-363.
109. Rao S.S., Attaluri A., Anderson L., et al. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol 2007, 5(8):959-963.
110. Skoog S.M., Bharucha A.E., Zinsmeister A.R. Comparison of breath testing with fructose and high fructose corn syrups in health and IBS. Neurogastroenterol Motil 2008, 20(5):505-511.
111. Choi Y.K., Kraft N., Zimmerman B., et al. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol 2008, 42(3):233-238.
112. Shepherd S.J., Gibson P.R. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006, 106(10):1631-1639.
113. Ledochowski M., Widner B., Bair H., et al. Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 2000, 35(10):1048-1052.
114. Fernandez-Banares F., Rosinach M., Esteve M., et al. Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment. Clin Nutr 2006, 25(5):824-831.
115. Austin G.L., Dalton C.B., Hu Y., et al. A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2009, 7(6). 706-708.e1.
116. Goldstein R., Braverman D., Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J 2000, 2(8):583-587.
117. Fung T.T., van Dam R.M., Hankinson S.E., et al. Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med 2010, 153(5):289-298.
118. Gibson P.R., Shepherd S.J. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol 2010, 25(2):252-258.
119. Ong D.K., Mitchell S.B., Barrett J.S., et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010, 25(8):1366-1373.
120. Argenzio R.A., Meuten D.J. Short-chain fatty acids induce reversible injury of porcine colon. Dig Dis Sci 1991, 36(10):1459-1468.
121. Soret R., Chevalier J., De Coppet P., et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 2010, 138(5):1772-1782.
122. Barrett J.S., Gearry R.B., Muir J.G., et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010, 31(8):874-882.
123. Bovee-Oudenhoven I.M., ten Bruggencate S.J., Lettink-Wissink M.L., et al. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats. Gut 2003, 52(11):1572-1578.
124. Thabane M., Simunovic M., Akhtar-Danesh N., et al. Development and validation of a risk score for post-infectious irritable bowel syndrome. Am J Gastroenterol 2009, 104(9):2267-2274.
125. Gearry R., Irving P.M., Barrett J.S., et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMPAs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis 2009, 3:8-14.
126. Shepherd S.J., Parker F.C., Muir J.G., et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008, 6(7):765-771.
127. Catsos P. IBS-free at last!: a revolutionary, new step-by-step method for those who have tried everything. Control IBS symptoms by limiting FODMAPS carbohydrates in your diet 2009, Pond Cove Press, Portland (ME).
128. Ananthakrishnan A.N., McGinley E.L., Saeian K. Length of office visits for gastrointestinal disease: impact of physician specialty. Am J Gastroenterol 2010, 105(8):1719-1725.